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Background
The purpose of this study is the systematic review of
literature on endovascular treatment (EVT) of patients
with superior vena cava syndrome (SVCS).
Methods
A systematic keyword-based research in online libraries
and databases from 1980 until today was performed. We
found 43 related publications. Specifically, 13 retrospec-
tive, clinical, observational studies with large patient series
(>10), 2 clinical studies reviews, 3 guidelines and 25 case
reports.
Results
The most frequent cause of superior vena cava syndrome
was lung cancer. Endovascular treatment of the syndrome
was accomplished via stent placement with or without
angioplasty. The technical success of the method was very
high (96.75%) and the corresponding clinical success
was similarly high (94%). Primary patency was 87.4% on
average, while secondary patency was 93.5%. The rate of
syndrome recurrence after stent placement varied from
13-20% and was not related to the technical method, but
it did depend on primary disease progression. The compli-
cations of the method are minimal and in very experi-
enced centers virtually zero.
Conclusions
Endovascular treatment of superior vena cava syndrome
with stent placement is a safe treatment option with
very high efficiency and immediate clinical benefit for
the patients. Therefore, we recommend endovascular
treatment as the first line therapeutic approach of the
syndrome.
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